Hiroyuki Tanaka

Vitamin D Is an Important Factor in Estrogen Biosynthesis of Both Female and Male Gonads*

Keiko Kinuta, Hiroyuki Tanaka, Tadashi Moriwake et al. · Endocrinology · 2000 · 521 citations

Medicine, Endocrinology, Physiology +17

Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial

Erik A. Imel, Francis H. Glorieux, Michael P. Whyte et al. · The Lancet · 2019 · 367 citations · Full text

Pharmacy, Pediatrics, Pharmacotherapy +4

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis

Karl Insogna, Karine Briot, Erik A. Imel et al. · Journal of Bone and Mineral Research · 2018 · 340 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients

Itsuro Endo, Seiji Fukumoto, Keiichi Ozono et al. · Bone · 2008 · 206 citations

Medicine, Endocrinology, Nephrology +10

Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period

Anthony A. Portale, Thomas O. Carpenter, Maria Luisa Brandi et al. · Calcified Tissue International · 2019 · 160 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17